However, treating the Fmr1 KO mice with bryostatin-1 for 5 weeks, a timescale comparable to several months of human treatment, had very limited or no therapeutic effects on the behavioral and cognitive deficits (Cogram et al., 2020). Here, FMR1 is linked to Cognitive impairment.